Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1202690014 | Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1478735011 | Ephedrine sulfate+hydroxyzine hydrochloride+theophylline 6.25mg/2.5mg/32.5mg syrup | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup (product) | est un(e) (attribut) | Hydroxyzine hydrochloride [antihististamine] (product) | false | Inferred relationship | Some | ||
| Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup (product) | est un(e) (attribut) | Product containing theophylline (medicinal product) | false | Inferred relationship | Some | ||
| Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup (product) | est un(e) (attribut) | Product containing ephedrine (medicinal product) | false | Inferred relationship | Some | ||
| Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup (product) | est un(e) (attribut) | Theophylline-containing product in oral dose form | false | Inferred relationship | Some | ||
| Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup (product) | est un(e) (attribut) | Ephedrine sulfate (product) | false | Inferred relationship | Some | ||
| Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup (product) | est un(e) (attribut) | Product containing hydroxyzine (medicinal product) | false | Inferred relationship | Some | ||
| Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup (product) | a pour principe actif (attribut) | Theophylline (substance) | false | Inferred relationship | Some | ||
| Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup (product) | a pour principe actif (attribut) | Hydroxyzine (substance) | false | Inferred relationship | Some | ||
| Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup (product) | a pour principe actif (attribut) | Smooth muscle relaxant (substance) | false | Inferred relationship | Some | ||
| Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup (product) | a pour principe actif (attribut) | Ephedrine (substance) | false | Inferred relationship | Some | ||
| Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup (product) | a pour principe actif (attribut) | Ephedrine sulfate | false | Inferred relationship | Some | ||
| Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup (product) | est un(e) (attribut) | Product containing ephedrine sulfate and hydroxyzine hydrochloride and theophylline (medicinal product) | false | Inferred relationship | Some | ||
| Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup (product) | a pour principe actif (attribut) | Hydroxyzine hydrochloride | false | Inferred relationship | Some | ||
| Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup (product) | a une forme pharmaceutique (attribut) | Conventional release oral syrup (dose form) | false | Inferred relationship | Some | ||
| Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup (product) | a pour principe actif (attribut) | Xanthine | false | Inferred relationship | Some | ||
| Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup (product) | a pour principe actif (attribut) | Musculoskeletal system agent (substance) | false | Inferred relationship | Some | ||
| Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup (product) | est un(e) (attribut) | Product containing ephedrine in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup (product) | est un(e) (attribut) | Theophylline-containing product in oral dose form | false | Inferred relationship | Some | ||
| Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup (product) | est un(e) (attribut) | Product containing hydroxyzine in oral dose form (medicinal product form) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR